Zobrazeno 1 - 10
of 109
pro vyhledávání: '"María A. Esteve-Pastor"'
Autor:
Marta Herrero-Brocal, Francisco Marín, Laura Valverde, Ana M. García-Barrios, Laura Fuertes, Cristina Cambra, Fernando Torres-Mezcua, Ignacio Hortelano, Beatriz Villamia, María Asunción Esteve-Pastor, Esteban Orenes-Piñero, Juan Gabriel Martínez Martínez, José Miguel Rivera-Caravaca, Juan M. Ruiz-Nodar
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 46, Iss , Pp 101209- (2023)
The introduction of high-sensitivity troponin (hsTn) assays has reduced the diagnosis of unstable angina (UA) in favor of non-ST elevation myocardial infarction (NSTEMI) in the context of non-ST elevation acute coronary syndrome (NSTEACS). It is uncl
Externí odkaz:
https://doaj.org/article/d0e31fa62a6d4fffbab2c2ea3576836e
Autor:
María Eugenia de la Morena-Barrio, Javier Corral, Cecilia López-García, Víctor Alonso Jiménez-Díaz, Antonia Miñano, Pablo Juan-Salvadores, María Asunción Esteve-Pastor, José Antonio Baz-Alonso, Ana María Rubio, Francisco Sarabia-Tirado, Miguel García-Navarro, Juan García-Lara, Francisco Marín, Vicente Vicente, Eduardo Pinar, Sergio José Cánovas, Gonzalo de la Morena
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundAortic valve replacement is the gold standard treatment for severe symptomatic aortic stenosis, but thrombosis of bioprosthetic valves (PVT) remains a concern.ObjectiveTo analyze the factors involved in the contact pathway during aortic val
Externí odkaz:
https://doaj.org/article/dddb298cffc9441fa5c3fa17c4b80718
Autor:
María Asunción Esteve-Pastor, Martín Ruiz-Ortiz, Javier Muñiz, Inmaculada Roldán-Rabadán, Déborah Otero, Ángel Cequier, Vicente Bertomeu-Martínez, Lina Badimón, Manuel Anguita, Gregory Y. H. Lip, Francisco Marín
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundAn integrated and holistic approach is increasingly advocated in patients with atrial fibrillation (AF), based on the “Atrial fibrillation Better Care (ABC) pathway: A, Avoid stroke with anticoagulation; B, better symptom management; C, c
Externí odkaz:
https://doaj.org/article/6ba1c2dcf68346a7816e8912ab899c36
Autor:
Lilian Grigorian-Shamagian, Klaus Edel, María Asunción Esteve-Pastor, Álvaro Aceña, Claudia Silva, Joana Delgado-Silva, Georges Ntaios, Eftychia Demerouti, Carlos Brotons
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
The main objective of cardiovascular disease (CVD) prevention is to reduce morbidity and mortality. Despite recommendations on evidence-based pharmacological treatment and lifestyle changes, the control of CV risk factors such as hypertension or dysl
Externí odkaz:
https://doaj.org/article/414fef5fb0bc46909dd9295b208c486a
Autor:
Vicente Bertomeu‐Gonzalez, José Moreno‐Arribas, María Asunción Esteve‐Pastor, Inmaculada Roldán‐Rabadán, Javier Muñiz, Paula Raña‐Míguez, Martín Ruiz‐Ortiz, Ángel Cequier, Vicente Bertomeu‐Martínez, Lina Badimón, Manuel Anguita, Gregory Y. H. Lip, Francisco Marín
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 1 (2020)
Background Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral anticoagulants for AF. Methods and Results Cons
Externí odkaz:
https://doaj.org/article/c7ef0660a3494c2ea72f49262f437615
Autor:
José Miguel Rivera-Caravaca, Francisco Marín, María Asunción Esteve-Pastor, Josefa Gálvez, Gregory Y.H. Lip, Vicente Vicente, Vanessa Roldán
Publikováno v:
BMJ Open, Vol 9, Iss 12 (2019)
Introduction Atrial fibrillation (AF) is characterised by a high stroke risk. Vitamin K antagonists (VKAs) are the most commonly used oral anticoagulants (OACs) in Spain, but their efficacy and safety depend on the time in therapeutic range of Intern
Externí odkaz:
https://doaj.org/article/00f63fa71ea846f7963f01d47fb9ed5b
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 2, Pp 207-212 (2018)
Background: Matrix metalloproteinase (MMP)-2 plays an important role in the remodeling of left ventricles (LVs) and right ventricles (RVs). We investigated the differences of MMP-2 expression between LV and RV in response to nandrolone decanoate (ND)
Externí odkaz:
https://doaj.org/article/170108ee01894081ae0d8822eafb9f2c
Autor:
María A Esteve-Pastor, José M Rivera-Caravaca, Vanessa Roldán, Marcelo Sanmartin Fernández, Fernando Arribas, Jaime Masjuan, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Esther Recalde, Alejandro I Pérez-Cabeza, José Manuel Vázquez Rodríguez, Carles Ràfols Priu, Manuel Anguita Sánchez, Gregory Y H Lip, Francisco Marin
Publikováno v:
Esteve-Pastor, M A, Rivera-Caravaca, J M, Roldán, V, Fernández, M S, Arribas, F, Masjuan, J, Barrios, V, Cosin-Sales, J, Freixa-Pamias, R, Recalde, E, Pérez-Cabeza, A I, Rodríguez, J M V, Priu, C R, Sánchez, M A, Lip, G Y H & Marin, F 2023, ' Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban : Observations from the prospective EMIR Registry ', European heart journal. Cardiovascular pharmacotherapy, vol. 9, no. 1, pp. 38-46 . https://doi.org/10.1093/ehjcvp/pvac060
Background Assessing bleeding risk during the decision-making process of starting oral anticoagulation (OAC) therapy in atrial fibrillation (AF) patients is essential. Several bleeding risk scores have been proposed for vitamin K antagonist users but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbffcb0afd9e1a00c1add23c67a0313
https://doi.org/10.1093/ehjcvp/pvac060
https://doi.org/10.1093/ehjcvp/pvac060
Autor:
Marcelo Sanmartín Fernández, Manuel Anguita Sánchez, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosin-Sales, María Asunción Esteve-Pastor, Roman Freixa-Pamias, Iñaki Lekuona, Alejandro I. Pérez-Cabeza, Isabel Ureña, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Francisco Marin
Publikováno v:
Cardiology Journal. 29:601-609
The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE.This was a post-authorization and observational study of AF adults treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bab2e783b7194357d4a445e71d56f35
https://doi.org/10.5603/cj.a2022.0044
https://doi.org/10.5603/cj.a2022.0044
Autor:
David Vivas, María Anguita-Gámez, Raquel Ferrandis, María Asunción Esteve-Pastor, Marysol Echeverri, Jesús Igualada, Manuel Anguita, Isabel Egocheaga, Beatriz Nozal-Mateo, Ane Abad-Motos, Elena Figuero, Nuria Bouzó-Molina, Teresa Lozano, Carlos Álvarez-Ortega, Javier Torres, María José Descalzo, Juan Carlos Catalá, Enrique Martín-Rioboo, Alejandra Molines, Rocío Rodríguez-Contreras, Manuel Carnero-Alcázar, Francisco Marín
Publikováno v:
Revista Española de Cardiología (English Edition).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f58eacf292e59ca9693086ff1399be6
https://doi.org/10.1016/j.rec.2023.03.003
https://doi.org/10.1016/j.rec.2023.03.003